CLINICAL_TRIALS
trial_result
· 2013-11-25
Clinical Trial Update: Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer [Phase 2]
Summary
A Phase 2 study of AG-013736 in patients with iodine-131-refractory thyroid cancer has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Thyroid Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2013-11-25